HLA restriction of spCD4 T-cell responses.

Slides:



Advertisements
Similar presentations
Melanoma donor (MD) NK cells are functionally impaired/exhausted.
Advertisements

Overview of next-generation sequencing, neoantigen prediction, and functional T-cell analyses. Overview of next-generation sequencing, neoantigen prediction,
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia
Patient T cells recognise a SMAD4V370A-containing neoepitope presented by autologous cancer cells. Patient T cells recognise a SMAD4V370A-containing neoepitope.
Key amino acid positions identified by association analysis are highlighted in three-dimensional ribbon models for the HLA-DR, HLA-DQ, HLA-A and HLA-DP.
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients by Raffaella.
T-Cell Response to Gluten in Patients With HLA-DQ2
Human Leukocyte Antigen–DO Regulates Surface Presentation of Human Leukocyte Antigen Class II–Restricted Antigens on B Cell Malignancies  Anita N. Kremer,
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.
Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
The absence of ADCC by nivolumab in vitro.
Neoantigen-specific TCR expansion in stimulated T-cell cultures.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
p38 MAPK activation is required for phosphorylation of Akt at Ser473.
Virus-specific T cell responses are detected in all MERS survivors.
Target cell lysis by ZnT8186–194-reactive CD8+ T cell clones.
Immunoperoxidase stainings for HLA-DR (A and B) and HLA-DP (C and D) in jejunal biopsy specimens from a healthy control (A and C) and from a type 1 diabetic.
Minor Histocompatibility Antigen DDX3Y Induces HLA-DQ5-Restricted T Cell Responses with Limited TCR-Vβ Usage Both In Vivo and In Vitro  David Laurin,
Figure 3 Alemtuzumab-induced changes in monocytes
Exosome-mediated inhibition of T cells is reversible.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors. Presence of anti-HPV E6/E7 epitope CD8+ T-cell responses in HPV+ OPSCC tumors.
Antigen specificity of direct tumor recognition by HTLV-1 Tax–reactive HTLs. The peptide Tax reactive HTLs 5G, 8E, and 9B (A-C) and peptide Tax reactive.
Recognition of naturally processed HTLV-1 Tax protein derived from HAM patient's PBMC. A, HTLV-1 Tax protein content was evaluated by Western blot analysis.
Specific recognition of HOM-MEL-40/SSX2-derived p pulsed targets by p stimulated T-cells from patients with HOM-MEL-40/SSX2 positive breast.
Interacting MDSCs and mast cells (MC) in human colon carcinoma and in the colon of AOM/DSS-induced tumor-bearing mice. Interacting MDSCs and mast cells.
Natural processing and presentation of the HOM-MEL-40/SSX2-derived p peptide. Natural processing and presentation of the HOM-MEL-40/SSX2-derived.
Exosomes inhibit the nuclear translocation of NFAT and NFκB following activation. Exosomes inhibit the nuclear translocation of NFAT and NFκB following.
Specificity of HOM-MEL-40/SSX2 p stimulated CD8+ T-cells.
The presence of soluble IL12p70 during moDCpoly stimulation of KIRnegNKG2Aneg cells results in a dominant population of multifunctional NKG2Apos NK cells.
Cytotoxicity of p5399–107-induced CTL cells.
Imatinib mesylate inhibits PDGF-mediated ERK and Akt activation.
NY-ESO-1-specific cytotoxic reactivity of CD4+ T cell clones.
CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.
A2/Melan-A multimer+ CD8+ allorestricted CTL clones derived from donor DR fail to significantly recognize DR self-targets. A2/Melan-A multimer+ CD8+ allorestricted.
CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.
Melanoma patient monocytes have altered expression of inflammatory and surface markers. Melanoma patient monocytes have altered expression of inflammatory.
Peptide dose-response curves were done to estimate the avidity of these HTL for peptide TARP1-14 (A) and TARP14-27 (B-E) using autologous PBMCs and dendritic.
HLA-DR53–restricted HTL responses to peptide TARP1-14.
Immune responses to 12MP and 6MHP.
The differential susceptibility to CTL-induced lysis does not involve Melan-A antigen expression. The differential susceptibility to CTL-induced lysis.
HLA-A*0201 restriction of SSX2-derived p stimulated CD8+ T-cells.
ALT-803 stimulates proliferation and activation of human NK cells and T cells in vitro. ALT-803 stimulates proliferation and activation of human NK cells.
TET2 interacts with KLF1 transcription factor.
Canonical but not adaptive NK-cell function is suppressed by Tregs.
Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,
PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.
Frequency of misrepair studies with increasing concentrations of antibodies against NHEJ repair proteins. Frequency of misrepair studies with increasing.
Coexpression of other immune genes with ImSig core signatures.
Characterizing an A*1101-restricted SSC-specific CD8+ cytotoxic T-cell clone. Characterizing an A*1101-restricted SSC-specific CD8+ cytotoxic T-cell clone.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Monocytes from melanoma patients are unresponsive to TLR3 agonists.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
Effect of bevacizumab on the proliferation of A2780 cells.
Hypoxia upregulates CD137 expression in T lymphocytes undergoing activation. Hypoxia upregulates CD137 expression in T lymphocytes undergoing activation.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
RRP1B interacts with TRIM28 and HP1α at regions associated with H3K9me3 and decreased gene expression. RRP1B interacts with TRIM28 and HP1α at regions.
Investigation of reactivity of D14 HLA-A
Induction of NY-ESO-1-specific CD4+ and CD8+ T cell responses after in vitro presensitization with NY-ESO-1 p or Ad2/ESO. Induction of NY-ESO-1-specific.
Cell counts of immune infiltrate and expression of galectin-1 and galectin-3 in the short-, medium-, and long-term survival cohorts. Cell counts of immune.
Comparison of MLTC responses to tumor/peptide stimuli at day 18 and day 34 of growth. Comparison of MLTC responses to tumor/peptide stimuli at day 18 and.
The inverse correlation between PARP1 and PD-L1, PAR, and p-STAT3 expression in surgical specimens of ovarian cancer. The inverse correlation between PARP1.
Varying the MHC-I affinity, TCR affinity or antigen dose alters the phenotype of CD8 T cells ex vivo. Varying the MHC-I affinity, TCR affinity or antigen.
RIL21 and checkpoint blockade restore IFNγ production in Tim-3+PD-1+ intratumoral NK cells from cancer patients. rIL21 and checkpoint blockade restore.
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Presentation transcript:

HLA restriction of spCD4 T-cell responses. HLA restriction of spCD4 T-cell responses. A, EMD640744-induced spCD4 responses were blocked with a pan-HLA class II–blocking (shown in 6 patients) but not a pan-HLA class I–blocking antibody (shown in 4 patients). B and C, HLA restriction of the two spCD4 T-cell response–inducing peptides, Sur96-104/M2 (B) and Sur18-27/K12 (C), was tested by stimulating T cells with the respective peptides in the presence of antibodies specifically blocking TCR interaction with HLA-DR, HLA-DQ, or HLA-DP. Each bar in a group represents one patient. Relevant HLA alleles of the corresponding patient are given below, behind the patient IDs. Values were normalized with the positive control (pos, stimulation with the respective peptide but without blocking antibodies) set to 100%. This was also done for the negative control (neg, stimulation without peptide and without antibodies). D, cells from patient C02P010 were tested as examples for reactivity to Sur96-104/M2 loaded either onto DP4 positive or onto DP1/DP2-expressing EBV-B–transformed lymphoblastic cell lines (EBV-LCL). Stefanie Gross et al. Cancer Immunol Res 2016;4:18-25 ©2016 by American Association for Cancer Research